Lu Chen, Shujie Zhai, Yayue Liu, Wenchen Gong, Feng Fang, Qiang Wu, Yunlong Cui, Wei Zhang, Huikai Li, Yongmei Li, Jihui Hao, Tianqiang Song. "Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial." Nature Communications, 2026. doi:10.1038/s41467-025-68108-2